| Comprehensive genomic profiles of small cell lung cancer J George, JS Lim, SJ Jang, Y Cun, L Ozretić, G Kong, F Leenders, X Lu, ... Nature 524 (7563), 47-53, 2015 | 1967 | 2015 |
| Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening M Kim, H Mun, CO Sung, EJ Cho, HJ Jeon, SM Chun, DJ Jung, TH Shin, ... Nature communications 10 (1), 3991, 2019 | 516 | 2019 |
| Genomic portrait of resectable hepatocellular carcinomas: Implications of RB1 and FGF19 aberrations for patient stratification SM Ahn, SJ Jang, JH Shim, D Kim, SM Hong, CO Sung, D Baek, F Haq, ... Hepatology 60 (6), 1972-1982, 2014 | 423 | 2014 |
| Epigenetic silencing of microRNA-373 to epithelial-mesenchymal transition in non-small cell lung cancer through IRAK2 and LAMP1 axes HS Seol, Y Akiyama, S Shimada, HJ Lee, T Im Kim, SM Chun, SR Singh, ... Cancer letters 353 (2), 232-241, 2014 | 104 | 2014 |
| Genomic Alterations of Anaplastic Thyroid Carcinoma Detected by Targeted Massive Parallel Sequencing in a BRAFV600E Mutation-Prevalent Area MJ Jeon, SM Chun, D Kim, H Kwon, EK Jang, TY Kim, WB Kim, YK Shong, ... Thyroid 26 (5), 683-690, 2016 | 91 | 2016 |
| Clinical relevance of gain-of-function mutations of p53 in high-grade serous ovarian carcinoma HJ Kang, SM Chun, KR Kim, I Sohn, CO Sung PloS one 8 (8), e72609, 2013 | 83 | 2013 |
| Mechanisms of acquired resistance to EGFR-tyrosine kinase inhibitor in Korean patients with lung cancer W Ji, CM Choi, JK Rho, SJ Jang, YS Park, SM Chun, WS Kim, JS Lee, ... BMC cancer 13, 1-8, 2013 | 82 | 2013 |
| In vitro selection of RNA against kanamycin B M Kwon, SM Chun, S Jeong, J Yu Molecules and cells 11 (3), 303-311, 2001 | 80 | 2001 |
| Spontaneous mutations in the single TTN gene represent high tumor mutation burden JH Oh, SJ Jang, J Kim, I Sohn, JY Lee, EJ Cho, SM Chun, CO Sung NPJ genomic medicine 5 (1), 33, 2020 | 75 | 2020 |
| Deregulated expression of microRNA-221 with the potential for prognostic biomarkers in surgically resected hepatocellular carcinoma SO Yoon, SM Chun, EH Han, J Choi, SJ Jang, SA Koh, S Hwang, E Yu Human pathology 42 (10), 1391-1400, 2011 | 75 | 2011 |
| Traditional serrated adenoma of the colorectum: clinicopathologic implications and endoscopic findings of the precursor lesions MJ Kim, EJ Lee, JP Suh, SM Chun, SJ Jang, DS Kim, DH Lee, SH Lee, ... American Journal of Clinical Pathology 140 (6), 898-911, 2013 | 72 | 2013 |
| ROS1 receptor tyrosine kinase, a druggable target, is frequently overexpressed in non-small cell lung carcinomas via genetic and epigenetic mechanisms HJ Lee, HS Seol, JY Kim, SM Chun, YA Suh, YS Park, S Kim, CM Choi, ... Annals of surgical oncology 20, 200-208, 2013 | 68 | 2013 |
| The somatic POLE P286R mutation defines a unique subclass of colorectal cancer featuring hypermutation, representing a potential genomic biomarker for immunotherapy SM Ahn, AA Ansari, J Kim, D Kim, SM Chun, J Kim, TW Kim, I Park, CS Yu, ... Oncotarget 7 (42), 68638, 2016 | 63 | 2016 |
| Development and characterization of a colon PDX model that reproduces drug responsiveness and the mutation profiles of its original tumor HS Seol, HJ Kang, SI Lee, NE Kim, T Im Kim, SM Chun, TW Kim, C sik Yu, ... Cancer letters 345 (1), 56-64, 2014 | 56 | 2014 |
| HER2 amplification and cetuximab efficacy in patients with metastatic colorectal cancer harboring wild-type RAS and BRAF JH Jeong, J Kim, YS Hong, D Kim, JE Kim, SY Kim, K Kim, YK Yoon, ... Clinical colorectal cancer 16 (3), e147-e152, 2017 | 51 | 2017 |
| Mutation burden and I index for detection of microsatellite instability in colorectal cancer by targeted next-generation sequencing JE Kim, SM Chun, YS Hong, K Kim, SY Kim, J Kim, CO Sung, EJ Cho, ... The Journal of Molecular Diagnostics 21 (2), 241-250, 2019 | 46 | 2019 |
| Prediction of core signaling pathway by using diffusion-and perfusion-based MRI radiomics and next-generation sequencing in isocitrate dehydrogenase wild-type glioblastoma JE Park, HS Kim, SY Park, SJ Nam, SM Chun, Y Jo, JH Kim Radiology 294 (2), 388-397, 2020 | 42 | 2020 |
| Good laboratory standards for clinical next-generation sequencing cancer panel tests J Kim, WY Park, NKD Kim, SJ Jang, SM Chun, CO Sung, J Choi, YH Ko, ... Journal of pathology and translational medicine 51 (3), 191, 2017 | 41 | 2017 |
| Immunogenomic landscape of hepatocellular carcinoma with immune cell stroma and EBV-positive tumor-infiltrating lymphocytes HJ Kang, JH Oh, SM Chun, D Kim, YM Ryu, HS Hwang, SY Kim, J An, ... Journal of hepatology 71 (1), 91-103, 2019 | 40 | 2019 |
| Multiple resistant factors in lung cancer with primary resistance to EGFR-TK inhibitors confer poor survival GW Kim, JS Song, CM Choi, JK Rho, SY Kim, SJ Jang, YS Park, SM Chun, ... Lung cancer 88 (2), 139-146, 2015 | 40 | 2015 |
